← Back to signals
INCY
STRONG BUYIncyte Corporation
Health Care
0.55
PEGY ratio
Rank #44
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 28.1% annually over 5 years.
INCY is trading at 13.7x earnings against 25.0% capped growth (actual 28.1%) (no dividend), giving a PEGY of 0.55. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
- • Growth rate capped at 25% for PEGY calculation (actual: 28.1%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.
Scan date: 2026-05-29
Valuation
13.7x
P/E Ratio
Growth
28.1%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.55
Denominator25.0%
EPS (TTM)$7.08
Market Data
Price$96.74
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.55→0.55(-0.00)
Rank
#46→#44(+2 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only